Skip to main content
. 2018 Mar 1;41(2):203–210. doi: 10.1002/clc.22909

Table 1.

Comparison of clinical characteristics, presentation, coronary involvement, management, and outcomes in recent SCAD cohorts

Cohort Tweet, 201712, a Saw, 20175 Lettieri, 20156, b Rogowski, 20177 Nakashima, 20168
No. of patients 323 327 134 64 63
Mean age, y 45 ± 9.6 52.5 ± 9.6 52 ± 11 53 ± 11.2 46 ± 10
Female sex 100 91 81 94 94
White race 95 82
BMI, kg/m2 24.9 ± 5 24.4 (21.5–28.3) 24.3 ± 3.5 24.8 ± 4.8 22.4 ± 4.2
DM 0.9 4.6 2 0 0
Dyslipidemia 35 26 33 52 23
HTN 27 36 51 45 33
Current smoker 0.6 10 34 28 32
Pregnancy associated 17 2 5 8
History of infertility therapy 18
History of hormonal birth control 86 0
History of postmenopausal HT 15 12 2
Migraines 30 36
History of depression 31 23
History of anxiety 31 13.5 2c
Extreme emotion/stress 13 48 29
Extreme exertion 12 28 19 10
FMD 30d 63 8e 8f
EVA 36d
Connective‐tissue disease 2 5 2
STEMI 40 26 49 30 87
NSTEMI 58 74 40 69 13
CV arrest 10 VT/VF 9 2.8 g Shock/arrest 16
Artery involvementf
LM 8 0.6 2.8 3 0
LAD 62 54 36 48 59
LCx 15 38 15 16 6
RCA 14 27 27 9 24
Ramus/OM/PDA/PLA 22 19 31
Multivessel 18 14 13 9 11
PCI 45 17 38 11 54
PCI lack of success 23 31 28 14 9
CABG 10 2.1 6 1.6 1.6
In‐hospital death 0 0 2.2 1.6
In‐hospital urgent revascularization 2 4.3 1.5 0
Follow‐up
Median F/U time 2.34 y (1.04–5.06 y) 3.1 y (1.49–5.49 y) 22 months (1–166 months) 4.5 y (1.8–8.4 y) 34 months (3–160 months)
F/U MI 18%; 21% 5‐y KM 16.8%; 4.8%/y 2 (1.6%) 4 (6.3%)g 18 (28.6%)
F/U SCAD 16%; 20% 5‐y KM 10.4%; 2.8%/y 4.7% 3 (4.7%) 22%; 27% 5‐y KM
F/U HF 2%; 3% 5‐yr KM 5 (3.9%) 0
F/U death 0 0.3%/y 4 (3.1%) 0b 1 (1.6%)

Abbreviations: CABG, coronary artery bypass grafting; CV, cardiovascular; EVA, extracoronary vascular abnormalities; FMD, fibromuscular dysplasia; F/U, follow‐up; HF, heart failure; HT, hormone therapy; HTN, hypertension; IQR, interquartile range; KM, Kaplan–Meier; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; LM, left main coronary artery; MI, myocardial infarction; NSTEMI, non–ST‐segment elevation myocardial infarction; OM, obtuse marginal artery; PCI, percutaneous coronary intervention; PDA, posterior descending artery; PLA, posterolateral artery; SCAD, spontaneous coronary artery dissection; SD, standard deviation; STEMI, ST‐segment elevation myocardial infarction; VF, ventricular fibrillation; VT, ventricular tachycardia.

Data are presented as %, mean ± SD, or median (IQR), unless otherwise noted.

a

Due to this study's focus on pregnancy‐associated SCAD, all patients included in this cohort were women.

b

11.9% of the patients in this cohort had atherosclerosis.

Documented as panic disorder.

If calculating percentages based on those imaged systematically for arteriopathies (n = 161), the percentage of FMD is 61% and EVA is 72%. EVA includes FMD but also noncoronary dilations, tortuosity, and dissection, as described elsewhere.21

c

Five patients of the 40 imaged had FMD (13%).

d

Five patients of the 24 imaged had FMD (21%).

e

One patient had in‐hospital cardiac arrest.

f

Denominators of the coronary artery percentages are total number of patients.

g

One patient with persistent SCAD had out‐of‐hospital cardiac arrest 16 days after initial diagnosis but was successfully resuscitated.